Furthermore, chemotherapy enhances the activity of tumor-killing immune cells (CD4+ and CD8+ T cells) in the TME while reducing the activity of suppressor immune cells (regulatory T cells and myeloid-derived suppressor cells) (Xue et al., 2021). This evidence concerns the gene CD8A and neoplasm.